B Bonavida

1.2k total citations
53 papers, 997 citations indexed

About

B Bonavida is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, B Bonavida has authored 53 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in B Bonavida's work include Immune Cell Function and Interaction (23 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immunotherapy and Immune Responses (8 papers). B Bonavida is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immunotherapy and Immune Responses (8 papers). B Bonavida collaborates with scholars based in United States, Australia and Greece. B Bonavida's co-authors include Anahid Jewett, Hideki Morimoto, Susan C. Wright, Shin Yonehara, L T Lebow, Janis V. Giorgi, Xiao-Hu Gan, Yoshinori Hasegawa, Shunsuke Mori and Kaoru Murakami-Mori and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

B Bonavida

52 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Bonavida United States 19 656 322 243 102 62 53 997
J. Hinrich Peters Germany 20 831 1.3× 542 1.7× 209 0.9× 84 0.8× 37 0.6× 33 1.4k
Brian E. Castle United States 12 860 1.3× 287 0.9× 244 1.0× 114 1.1× 79 1.3× 16 1.2k
Mireille Viguier France 18 735 1.1× 392 1.2× 231 1.0× 109 1.1× 60 1.0× 29 1.2k
C. Kurahara United States 9 648 1.0× 353 1.1× 154 0.6× 98 1.0× 73 1.2× 12 1.1k
KA Smith United States 9 1.1k 1.6× 330 1.0× 238 1.0× 267 2.6× 115 1.9× 15 1.6k
Helen Quill United States 19 1.0k 1.6× 344 1.1× 239 1.0× 217 2.1× 73 1.2× 33 1.5k
Dina G. Fischer Israel 18 650 1.0× 418 1.3× 235 1.0× 193 1.9× 55 0.9× 29 1.2k
Josette Péguet‐Navarro France 24 1.1k 1.6× 288 0.9× 224 0.9× 37 0.4× 38 0.6× 44 1.5k
Christophe Losberger Switzerland 13 349 0.5× 423 1.3× 121 0.5× 99 1.0× 54 0.9× 13 962
T Diamantstein Germany 19 747 1.1× 242 0.8× 227 0.9× 151 1.5× 31 0.5× 57 1.2k

Countries citing papers authored by B Bonavida

Since Specialization
Citations

This map shows the geographic impact of B Bonavida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Bonavida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Bonavida more than expected).

Fields of papers citing papers by B Bonavida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Bonavida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Bonavida. The network helps show where B Bonavida may publish in the future.

Co-authorship network of co-authors of B Bonavida

This figure shows the co-authorship network connecting the top 25 collaborators of B Bonavida. A scholar is included among the top collaborators of B Bonavida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Bonavida. B Bonavida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baritaki, Stavroula, et al.. (2025). Targeting the YY1-Bcl2-c-Myc Axis in the treatment of non-Hodgkin lymphoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189395–189395.
2.
Bonavida, B, et al.. (2025). PCO25-216: The RKIP/HIF-1 Axis in Cancer Immune Evasion. Journal of the National Comprehensive Cancer Network. 23(3.5). 1 indexed citations
3.
Bonavida, B & Mario I. Vega. (2005). Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's Lymphoma. Drug Resistance Updates. 8(1-2). 27–41. 8 indexed citations
4.
Cavalcanti, Marta Guimarães, Anahid Jewett, & B Bonavida. (1999). Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cells.. International Journal of Oncology. 14(2). 361–6. 12 indexed citations
5.
Jewett, Anahid, Marta Guimarães Cavalcanti, Janis V. Giorgi, & B Bonavida. (1997). Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system. The Journal of Immunology. 158(11). 5492–5500. 29 indexed citations
6.
Jewett, Anahid, Xiao-Hu Gan, L T Lebow, & B Bonavida. (1996). Differential secretion of TNF-? and IFN-? by human peripheral blood-derived NK subsets and association with functional maturation. Journal of Clinical Immunology. 16(1). 46–54. 38 indexed citations
7.
Sarna, Gregory, Herbert I. Machleder, James J. Collins, et al.. (1994). A Comparative Study of Intravenous Versus Intralymphatic Interleukin-2, with Assessment of Effects of Interleukin-2 on Both Peripheral Blood and Thoracic-Duct Lymph. Journal of Immunotherapy. 15(2). 140–146. 4 indexed citations
8.
Lebow, L T, Anahid Jewett, & B Bonavida. (1993). Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. The Journal of Immunology. 150(1). 320–329. 7 indexed citations
9.
10.
Bonavida, B. (1991). Further characterization of natural killer cytotoxic factor nkcf and anti nkcf antibodies. The FASEB Journal. 5(4). 727. 1 indexed citations
11.
Zighelboim, Jacob, et al.. (1990). Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.. PubMed. 9(4). 283–96. 4 indexed citations
12.
Nio, Yoshinori, Jacob Zighelboim, Jonathan S. Berek, & B Bonavida. (1989). Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells. Cancer. 64(2). 434–441. 16 indexed citations
13.
Hasegawa, Yoshinori & B Bonavida. (1989). Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells.. The Journal of Immunology. 142(8). 2670–2676. 28 indexed citations
14.
Bonavida, B & Susan C. Wright. (1987). Multistage Model of Natural Killer Cell-Mediated Cytotoxicity Involving Nkcf as Soluble Cytotoxic Mediators. Advances in cancer research. 49. 169–187. 8 indexed citations
15.
Wright, Susan C. & B Bonavida. (1981). Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes.. The Journal of Immunology. 126(4). 1516–1521. 111 indexed citations
16.
Bonavida, B, Ian V. Hutchinson, & Amy Thomas. (1979). Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens.. PubMed. 11(1). 874–7. 6 indexed citations
17.
Bonavida, B & Ian V. Hutchinson. (1978). Modulation of T-dependent cell-mediated immune responses by antigen-reactive cell opsonization and active suppression.. PubMed. 10(1). 31–5. 2 indexed citations
18.
Hutchinson, Ian V., Janet Roman, & B Bonavida. (1978). Opsonization of anti-tumor reactive lymphocytes in sjl/j mice bearing spontaneous reticulum cell sarcomas (rcs). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 34. 2 indexed citations
19.
Bonavida, B. (1977). Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.. The Journal of Experimental Medicine. 145(2). 293–301. 33 indexed citations
20.
Rao, V. S. N. & B Bonavida. (1976). Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.. The Mouseion at the JAXlibrary (Jackson Laboratory). 36(4). 1384–91. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Hinrich Peters Breakdown of academic impact, for papers by Brian E. Castle Breakdown of academic impact, for papers by Mireille Viguier Breakdown of academic impact, for papers by C. Kurahara Breakdown of academic impact, for papers by KA Smith Breakdown of academic impact, for papers by Helen Quill Breakdown of academic impact, for papers by Dina G. Fischer Breakdown of academic impact, for papers by Josette Péguet‐Navarro Breakdown of academic impact, for papers by Christophe Losberger Breakdown of academic impact, for papers by T Diamantstein
Rankless by CCL
2026